Duloxetine in the treatment of chronic myofascial pain syndromes. O.H. Morozova, A.A. Yaroshevskiy. Neuronus. 2017

Duloxetine in the treatment of chronic myofascial pain syndromes. O.H. Morozova, A.A. Yaroshevskiy. Neuronus. 2017

Duloxetine in the treatment of chronic myofascial pain syndromes.  O.H.  Morozova, A.A.  Yaroshevskiy.  Neuronus. 2017

The efficacy of the Simoda drug in the treatment of chronic myofascial pain syndromes was revealed in our study. The administration of the drug at a dose of 30 mg made it possible to achieve faster control over pain and depressive manifestations, reduce the duration of NSAIDs, and in some cases to refuse them. The analgesic effect of the Simoda drug developed earlier (on the 7th day) than the antidepressant (on the 15th day).

The analgesic effect of the Simoda drug developed earlier (on the 7th day) than the antidepressant (on the 15th day).